Non-opioid Based Pain Control After Thyroidectomy
Use of Enhanced Recovery After Surgery (ERAS) in Minimizing Opioid Use for Patients Undergoing Thyroidectomy
1 other identifier
interventional
100
1 country
1
Brief Summary
Pain control modalities were evaluated after thyroidectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Jul 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 24, 2018
CompletedFirst Submitted
Initial submission to the registry
May 14, 2019
CompletedFirst Posted
Study publicly available on registry
June 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2019
CompletedMay 12, 2020
May 1, 2020
1 year
May 14, 2019
May 8, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
visual analog scale pain level
Pain level from 0 (no pain) to 10 (worst pain imaginable).
1 hour post operatively
visual analog scale pain level
Pain level from 0 (no pain) to 10 (worst pain imaginable).
6 hour post operatively
visual analog scale pain level
Pain level from 0 (no pain) to 10 (worst pain imaginable).
24 hour post operatively
visual analog scale pain level
Pain level from 0 (no pain) to 10 (worst pain imaginable).
7 days post operatively
Secondary Outcomes (1)
opioid use
with the first 24 hours post operatively
Study Arms (2)
Acetaminophen and hydrocodone based pain control
ACTIVE COMPARATORPatients receive acetaminophen 650mg every 4 for pain level 1-3, hydrocodone/acetaminophen 5/325mg every 4 for pain level 4-6, or hydrocodone/acetaminophen 10/650mg every 4 for pain level 7-10 on as needed basis.
Acetaminophen and ibuprofen based pain control
EXPERIMENTALPatients receive standing dose of acetaminophen 650mg every 8 hours and ibuprofen 800mg every 8 hours with alternating ibuprofen and acetaminophen every 4 hours.
Interventions
Patients receive acetaminophen 650mg every 4 for pain level 1-3, hydrocodone/acetaminophen 5/325mg every 4 for pain level 4-6, or hydrocodone/acetaminophen 10/650mg every 4 for pain level 7-10 on as needed basis.
Patients receive standing dose of acetaminophen 650mg every 8 hours and ibuprofen 800mg every 8 hours with alternating ibuprofen and acetaminophen every 4 hours.
Eligibility Criteria
You may qualify if:
- thyroid disease
You may not qualify if:
- currently on opioid pain medications
- on opioid pain meds in last 30 days
- cannot take non-opioid medications
- require more extensive operation than thyroidectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Related Publications (4)
Francis DO, Randolph G, Davies L. Nationwide Variation in Rates of Thyroidectomy Among US Medicare Beneficiaries. JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1122-1125. doi: 10.1001/jamaoto.2017.1746.
PMID: 29049468RESULTBrummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert ASB, Kheterpal S, Nallamothu BK. New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults. JAMA Surg. 2017 Jun 21;152(6):e170504. doi: 10.1001/jamasurg.2017.0504. Epub 2017 Jun 21.
PMID: 28403427RESULTWilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. doi: 10.1136/bmj.322.7284.473. No abstract available.
PMID: 11222424RESULTKehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. doi: 10.1016/s0002-9610(02)00866-8.
PMID: 12095591RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Felger, MD
Medstar Health Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2019
First Posted
June 17, 2019
Study Start
July 24, 2018
Primary Completion
August 1, 2019
Study Completion
September 30, 2019
Last Updated
May 12, 2020
Record last verified: 2020-05